Search filters

Authors whose works are in public domain in at least one jurisdiction

List of works by Elena Fogari

A comparison of the effects of pioglitazone and rosiglitazone combined with glimepiride on prothrombotic state in type 2 diabetic patients with the metabolic syndrome

scientific article published on 29 December 2004

A randomized, double-blind, comparative therapy evaluating sitagliptin versus glibenclamide in type 2 diabetes patients already treated with pioglitazone and metformin: a 3-year study

scientific article published on 21 February 2013

A randomized, double-blind, placebo-controlled trial evaluating sitagliptin action on insulin resistance parameters and β-cell function

scientific article published on 15 October 2012

Acarbose actions on insulin resistance and inflammatory parameters during an oral fat load

scientific article published on 28 November 2010

Adipocytokine levels in obese and non-obese subjects: an observational study

scientific article published in August 2013

Berberis aristata/Silybum marianum fixed combination on lipid profile and insulin secretion in dyslipidemic patients.

scientific article

Blood pressure control and inflammatory markers in type 2 diabetic patients treated with pioglitazone or rosiglitazone and metformin

scientific article published in May 2007

Comparison between metalloproteinases-2 and -9 in healthy subjects, diabetics, and subjects with acute coronary syndrome.

scientific article published on 26 November 2007

Comparison between orlistat plus l-carnitine and orlistat alone on inflammation parameters in obese diabetic patients

scientific article published on 16 November 2010

Comparison of orlistat treatment and placebo in obese type 2 diabetic patients

scientific article published on August 2010

Comparison of the effects of telmisartan and nifedipine gastrointestinal therapeutic system on blood pressure control, glucose metabolism, and the lipid profile in patients with type 2 diabetes mellitus and mild hypertension: a 12-month, randomized,

scientific article published in August 2004

Different actions of losartan and ramipril on adipose tissue activity and vascular remodeling biomarkers in hypertensive patients

scientific article published on 25 November 2010

Differential effect of glimepiride and rosiglitazone on metabolic control of type 2 diabetic patients treated with metformin: a randomized, double-blind, clinical trial

scientific article published in March 2006

Differential effects of candesartan and olmesartan on adipose tissue activity biomarkers in type II diabetic hypertensive patients

scientific article published on 27 May 2010

Effect of amlodipine-atorvastatin combination on fibrinolysis in hypertensive hypercholesterolemic patients with insulin resistance

scientific article published in September 2004

Effect of pioglitazone and acarbose on endothelial inflammation biomarkers during oral glucose tolerance test in diabetic patients treated with sulphonylureas and metformin

scientific article published on October 2010

Effects of 1-year orlistat treatment compared to placebo on insulin resistance parameters in patients with type 2 diabetes ⬇️

scientific article published on August 4, 2011

Effects of a combination of sitagliptin plus metformin vs metformin monotherapy on glycemic control, β-cell function and insulin resistance in type 2 diabetic patients

scientific article published on 9 June 2012

Effects of a standardized oral fat load on vascular remodelling markers in healthy subjects

scientific article published on 29 March 2010

Effects of an olmesartan/amlodipine fixed dose on blood pressure control, some adipocytokines and interleukins levels compared with olmesartan or amlodipine monotherapies

scientific article

Effects of canrenone in patients with metabolic syndrome.

scientific article

Effects of exenatide and metformin in combination on some adipocytokine levels: a comparison with metformin monotherapy

scientific article published on 23 April 2013

Effects of insulin therapy with continuous subcutaneous insulin infusion (CSII) in diabetic patients: comparison with multi-daily insulin injections therapy (MDI).

scientific article

Effects of long chain ω-3 fatty acids on metalloproteinases and their inhibitors in combined dyslipidemia patients

Effects of n-3 PUFA on insulin resistance after an oral fat load

scholarly article by Giuseppe Derosa et al published 14 June 2011 in European Journal of Lipid Science and Technology

Effects of n-3 PUFAs on postprandial variation of metalloproteinases, and inflammatory and insulin resistance parameters in dyslipidemic patients: Evaluation with euglycemic clamp and oral fat load ⬇️

scientific article published on February 27, 2012

Effects of nateglinide and glibenclamide on prothrombotic factors in naïve type 2 diabetic patients treated with metformin: a 1-year, double-blind, randomized clinical trial

scientific article published on 16 November 2007

Enalapril/lercanidipine combination on markers of cardiovascular risk: a randomized study.

scientific article published on 4 April 2014

Evaluation of emerging biomarkers in cardiovascular risk stratification of hypertensive patients: a 2-year study

scientific article published on 14 August 2012

Evaluation of metalloproteinase 2 and 9 levels and their inhibitors in combined dyslipidemia

scientific article

Evaluation of safety and efficacy of a fixed olmesartan/amlodipine combination therapy compared to single monotherapies

scientific article published on 2 July 2013

Exenatide or glimepiride added to metformin on metabolic control and on insulin resistance in type 2 diabetic patients

scientific article published in June 2011

Exenatide plus metformin compared with metformin alone on β-cell function in patients with Type 2 diabetes

scientific article published in December 2012

Glyco-metabolic profile among type 2 diabetic patients with erectile dysfunction

scientific article published on 26 May 2012

Long-term effects of glimepiride or rosiglitazone in combination with metformin on blood pressure control in type 2 diabetic patients affected by the metabolic syndrome: a 12-month, double-blind, randomized clinical trial

scientific article

Metabolic and antihypertensive effects of moxonidine and moxonidine plus irbesartan in patients with type 2 diabetes mellitus and mild hypertension: a sequential, randomized, double-blind clinical trial

scientific article published in April 2007

Metabolic effects of pioglitazone and rosiglitazone in patients with diabetes and metabolic syndrome treated with glimepiride: a twelve-month, multicenter, double-blind, randomized, controlled, parallel-group trial

scientific article

Metalloproteinase-2 and -9 in diabetic and nondiabetic subjects during acute coronary syndromes.

scientific article published in January 2007

Metalloproteinases in Diabetics and Nondiabetics during Acute Coronary Syndromes and after 3 Months

scientific article published on 01 July 2007

Modification of vascular and inflammation biomarkers after OGTT in overweight healthy and diabetic subjects

scientific article published on 14 January 2010

Modulation of adipokines and vascular remodelling markers during OGTT with acarbose or pioglitazone treatment

scientific article published on 13 October 2009

Nateglinide and glibenclamide metabolic effects in naïve type 2 diabetic patients treated with metformin

scientific article published in February 2009

Olmesartan/amlodipine combination versus olmesartan or amlodipine monotherapies on blood pressure and insulin resistance in a sample of hypertensive patients

scientific article published on 6 September 2012

Oral fat load effects on inflammation and endothelial stress markers in healthy subjects.

scientific article published on 24 May 2009

Oral glucose tolerance test effects on endothelial inflammation markers in healthy subjects and diabetic patients

scientific article published on 4 September 2009

Orlistat and L-carnitine compared to orlistat alone on insulin resistance in obese diabetic patients

scientific article published on 30 July 2010

Pioglitazone compared to glibenclamide on lipid profile and inflammation markers in type 2 diabetic patients during an oral fat load

scientific article published on 17 May 2011

RETRACTED: Acarbose on insulin resistance after an oral fat load: a double-blind, placebo controlled study.

retracted scientific article

RETRACTED: Different aspects of sartan + calcium antagonist association compared to the single therapy on inflammation and metabolic parameters in hypertensive patients

retracted article; published in February 2014

RETRACTED: Evaluation of the positive effects on insulin-resistance and β-cell measurements of vildagliptin in addition to metformin in type 2 diabetic patients

retracted scientific article published on 26 April 2013

Results from a 12 months, randomized, clinical trial comparing an olmesartan/amlodipine single pill combination to olmesartan and amlodipine monotherapies on blood pressure and inflammation

scientific article published on 30 August 2013

Retraction notice to "Enalapril/lercanidipine combination on markers of cardiovascular risk: a randomized study": J Am Soc Hypertens 8 (2014) 422-428

scientific article published on 23 October 2015

Retraction notice to "Variation of some inflammatory markers in hypertensive patients after 1 year of olmesartan/amlodipine single-pill combination compared with olmesartan or amlodipine monotherapies": J Am Soc Hypertens 7 (2013) 32-39

scientific article published on 23 October 2015

Rosiglitazone therapy improves insulin resistance parameters in overweight and obese diabetic patients intolerant to metformin

scientific article published on 10 March 2008

Sibutramine effect on metabolic control of obese patients with type 2 diabetes mellitus treated with pioglitazone

scientific article

Sitagliptin added to previously taken antidiabetic agents on insulin resistance and lipid profile: a 2-year study evaluation

scientific article published on 8 October 2012

Synergistic effect of doxazosin and acarbose in improving metabolic control in patients with impaired glucose tolerance

scientific article published in January 2006

Ultrasonography modifications of visceral and subcutaneous adipose tissue after pioglitazone or glibenclamide therapy combined with rosuvastatin in type 2 diabetic patients not well controlled by metformin

scientific article published in September 2013

Variation in inflammatory markers and glycemic parameters after 12 months of exenatide plus metformin treatment compared with metformin alone: a randomized placebo-controlled trial

scientific article published on 6 June 2013

Variation of some inflammatory markers in hypertensive patients after 1 year of olmesartan/amlodipine single-pill combination compared with olmesartan or amlodipine monotherapies

scientific article published in January 2013

Variations in inflammatory biomarkers following the addition of sitagliptin in patients with type 2 diabetes not controlled with metformin

scientific article published in March 2012

Vildagliptin action on some adipocytokine levels in type 2 diabetic patients: a 12-month, placebo-controlled study

scientific article published on 3 November 2012

Vildagliptin added to metformin on β-cell function after a euglycemic hyperinsulinemic and hyperglycemic clamp in type 2 diabetes patients

scientific article published on 18 April 2012

Vildagliptin compared to glimepiride on post-prandial lipemia and on insulin resistance in type 2 diabetic patients

scientific article published on 23 April 2014

Paulina is supported by:

About Paulina

Help